Maybe H.P. Lovecraft was really a prophet of biotech when he wrote "That
is not dead which can eternal lie," as it clearly seems like there are
certain biotechs that come back again and again… and again. While the failure of AEterna Zentaris' (AEZS)
drug perifosine in colorectal cancer led to a major drop in the share
price and the end of a variety of silly rumors regarding the company's
prospects of being taken over by a Big Pharma company, it looks like the
company has once again attracted some hope and optimism.
Follow this link to continue to the full article:
Here We Go Again With AEterna Zentaris ... Again
No comments:
Post a Comment